Afatinib With Pembrolizumab for Treatment of Patients With Locally Advanced/Metastatic Squamous Cell Carcinoma of the Lung: The LUX-Lung IO/KEYNOTE 497 Study Protocol.
Clinical Lung Cancer.
Times cited: 1
Dabrafenib in patients with BRAFV600E-positive advanced non-small-cell lung cancer: A single-arm, multicentre, open-label, phase 2 trial.
The Lancet Oncology.
Times cited: 154
Genotype analysis of the VNTR polymorphism in the SMYD3 histone methyltransferase gene: Lack of correlation with the level of histone H3 methylation in NSCLC tissues or with the risk of NSCLC.
International Journal of Cancer.
Times cited: 3
Global histone modifications predict prognosis of resected non-small-cell lung cancer.
Journal of Clinical Oncology.
Times cited: 192
- Perspectives on salvage therapy for non-small-cell lung cancer: Commentary. ONCOLOGY. 2005 Comment
- EGFR-TKIs in the first-line treatment of NSCLC. Signal. 2005 Editorial Article